Travere Therapeutics
TVTX
TVTX
111 hedge funds and large institutions have $710M invested in Travere Therapeutics in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
111
Holders Change
-8
Holders Change %
-6.72%
% of All Funds
2.97%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
11
Increased
53
Reduced
31
Closed
18
Calls
$28.5M
Puts
$36.7M
Net Calls
-$8.27M
Net Calls Change
+$12.5M
Top Buyers
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$23.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.7M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$9.8M |
| 4 |
Millennium Management
New York
|
+$7.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.48M |
Top Sellers
| 1 |
SAM
Senzar Asset Management
New York
|
-$14M |
| 2 |
BC
Broadfin Capital
New York
|
-$5.29M |
| 3 |
AC
Amici Capital
New York
|
-$4.99M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$3.51M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$2.92M |
